25% Dextrose Infant

CHEBI:CHEBI_755771

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
727518
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20241231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
active_ingredient_name
DEXTROSE MONOHYDRATE
application_number
NDA019445
unii
LX22YL083G
active_ingredient_strength
250 mg/mL
labeler_name
HF Acquisition Co. LLC, DBA Health First
manufacturer_name
HF Acquisition Co. LLC, DBA Health First
marketing_start_date
20180819
package_marketing_start_date
20180819
generic_name
25% Dextrose Infant
brand_name
25% Dextrose Infant
brand_name_base
25% Dextrose Infant
product_ndc
51662-1213
spl_id
ef6a78fb-553f-a83e-e053-2995a90a6164
package_ndc
51662-1213-1
package_description
1 SYRINGE, PLASTIC in 1 CARTON (51662-1213-1) / 10 mL in 1 SYRINGE, PLASTIC
spl_set_id
73d04839-a2bb-65dd-e053-2991aa0a82ca
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class